Skip to content
Accessibility help
Search NICE…
Menu
Sign in
Guidance
Standards and indicators
Clinical Knowledge Summaries (CKS)
British National Formulary (BNF)
BNF for Children (BNFC)
Life sciences
More from NICE
Home
NICE guidance
In consultation
In consultation: Guidance and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Deferred
Awaiting development
Topic prioritisation
Filter
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Consultation end date
Consultation end date
From date
To date
Apply date filters
Type
Type
Guidance (21)
Guidance programme
Guidance programme
Clinical guidelines (1)
Early value assessment (2)
HealthTech guidance (4)
Interventional procedures guidance (2)
NICE guidelines (1)
NICE process and methods (1)
Technology appraisal guidance (15)
HealthTech approach
HealthTech approach
Early use (2)
Interventional procedure (2)
Apply filters
Showing 11 to 20 of 21
Sort by
Date
Title
Apply sorting
Guidance and quality standards in consultation
Title
Consultation
Type
Consultation end date
Niraparib with abiraterone acetate and prednisone for treating hormone-sensitive metastatic prostate cancer [ID6595]
Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators
Technology appraisal guidance
19 June 2026
Zongertinib for treating HER2-mutated unresectable or metastatic non-small-cell lung cancer ID6573
Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators
Technology appraisal guidance
18 June 2026
Avapritinib for treating inadequately controlled moderate to severe indolent systemic mastocytosis [ID6578]
Draft guidance
Technology appraisal guidance
18 June 2026
Inavolisib with palbociclib and fulvestrant for treating recurrent hormone receptor-positive HER2-negative PIK3CA-positive advanced breast cancer after adjuvant endocrine treatment [ID6425]
Draft guidance
Technology appraisal guidance
18 June 2026
Tafasitamab with lenalidomide and rituximab for treating relapsed or refractory follicular lymphoma after 1 or more systemic treatments [ID6413]
Draft guidance
Technology appraisal guidance
17 June 2026
Endouterine-ultrasound guided transcervical radiofrequency ablation for fibroids
Draft scope consultation
HealthTech guidance
16 June 2026
Atezolizumab with chemotherapy for adjuvant treatment of stage 3 colorectal cancer with high microsatellite instability or mismatch repair deficiency [ID6646]
Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators
Technology appraisal guidance
16 June 2026
Transvaginal radiofrequency ablation for symptomatic uterine fibroids
Draft scope consultation
HealthTech guidance
16 June 2026
Diabetes in pregnancy: management from preconception to the postnatal period - Managing type 1 diabetes (T1D) using hybrid closed loops (update)
Draft guidance consultation
NICE guideline
16 June 2026
Digital technologies for the early detection and initial diagnosis of adult hearing loss (provisional title)
Scoping
HealthTech guidance
16 June 2026
Previous page
1
Current page
2
3
Page
2
of
3
Next page
Results per page
10
25
50
All
Back to top